CONCENTRATION OF INFLIXIMAB IN THE NON-INFLAMED MUCOSA AS A PREDICTOR FOR SECONDARY LOSS OF RESPONSE TO INFLIXIMAB FOR CROHN'S DISEASE PATIENTS: A 4-YEAR PROSPECTIVE STUDY

被引：0
|
作者：
Yoshihara, Takeo
Shinzaki, Shinichiro
Amano, Takahiro
Otake, Yuriko
Tani, Mizuki
Iwatani, Shuko
Tsujii, Yoshiki
Hayashi, Yoshito
Inoue, Takahiro
Watabe, Kenji
Iijima, Hideki
Takehara, Tetsuo
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1815
引用
收藏
页码：S1135 / S1135
页数：1
相关论文
共 50 条
  • [31] THERAPEUTIC GAIN OF CONTINUED, LONG-TERM INFLIXIMAB THERAPY IN CROHN'S DISEASE PATIENTS WITH RESPONSE BUT NON-REMISSION AFTER ONE YEAR OF INFLIXIMAB THERAPY
    Buhl, Sine
    Borghede, Marta K.
    Brynskov, Jorn
    Steenholdt, Casper
    Rasmussen, Maria
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2018, 154 (06) : S623 - S624
  • [32] Therapeutic Strategy for Crohn's Disease with a Loss of Response to Infliximab: A Single-Center Retrospective Study
    Nagata, Yutaka
    Esaki, Motohiro
    Umeno, Junji
    Fuyuno, Yuta
    Ikegami, Koji
    Maehata, Yuji
    Asano, Kouichi
    Moriyama, Tomohiko
    Nakamura, Shotaro
    Kitazono, Takanari
    Matsumoto, Takayuki
    DIGESTION, 2015, 91 (01) : 50 - 56
  • [33] Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response
    Kim, Eun Sil
    Kwon, Yiyoung
    Choe, Yon Ho
    Kim, Mi Jin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [34] CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn's disease
    Yang, Tian
    Feng, Jing
    Yao, Ruchen
    Feng, Qi
    Shen, Jun
    INSIGHTS INTO IMAGING, 2024, 15 (01)
  • [35] CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease
    Tian Yang
    Jing Feng
    Ruchen Yao
    Qi Feng
    Jun Shen
    Insights into Imaging, 15
  • [36] Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan
    Fukushima, Kouhei
    Sugita, Akira
    Futami, Kitaro
    Takahashi, Ken-Ichi
    Motoya, Satoshi
    Kimura, Hideaki
    Yoshikawa, Shusaku
    Kinouchi, Yoshitaka
    Iijima, Hideki
    Endo, Katsuya
    Hibi, Toshihumi
    Watanabe, Mamoru
    Sasaki, Iwao
    Suzuki, Yasuo
    SURGERY TODAY, 2018, 48 (06) : 584 - 590
  • [37] Postoperative therapy with infliximab for Crohn’s disease: a 2-year prospective randomized multicenter study in Japan
    Kouhei Fukushima
    Akira Sugita
    Kitaro Futami
    Ken-Ichi Takahashi
    Satoshi Motoya
    Hideaki Kimura
    Shusaku Yoshikawa
    Yoshitaka Kinouchi
    Hideki Iijima
    Katsuya Endo
    Toshihumi Hibi
    Mamoru Watanabe
    Iwao Sasaki
    Yasuo Suzuki
    Surgery Today, 2018, 48 : 584 - 590
  • [38] Prospective study of phArmaCokinetics of InFliximab during induction in patients with Crohn's disease and ulcerative colitis (PACIFIC)
    Liefferinckx, C.
    Bossuyt, P.
    Thomas, D.
    Rahier, J. F.
    Louis, E.
    Baert, F.
    Dewint, P.
    Pouillon, L.
    Lambrecht, G.
    Vermeire, S.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S343 - S344
  • [39] PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)
    Liefferinckx, Claire
    Bossuyt, Peter
    Thomas, Debby
    Rahier, Jean-Francois
    Louis, Edouard
    Baert, Filip J.
    Dewint, Pieter
    Pouillon, Lieven
    Lambrecht, Guy
    Vermeire, Severine
    Franchimont, Denis
    GASTROENTEROLOGY, 2020, 158 (06) : S456 - S456
  • [40] In Pediatric Patients With Crohn's Disease, Dependency or Loss of Response Are Commonly Observed in Long Term Infliximab Treatment
    Smets, Francoise N.
    Wanty, Catherine
    Stephenne, Xavier
    Sokal, Etienne M.
    GASTROENTEROLOGY, 2011, 140 (05) : S514 - S514
12345